Clearside Biomedical Stock Alpha and Beta Analysis
| CLSD Stock | USD 1.08 0.06 5.88% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Clearside Biomedical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Clearside Biomedical over a specified time horizon. Remember, high Clearside Biomedical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Clearside Biomedical's market risk premium analysis include:
Beta 0.0406 | Alpha 0.22 | Risk 5.25 | Sharpe Ratio 0.0451 | Expected Return 0.24 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Clearside |
Clearside Biomedical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Clearside Biomedical market risk premium is the additional return an investor will receive from holding Clearside Biomedical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Clearside Biomedical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Clearside Biomedical's performance over market.| α | 0.22 | β | 0.04 |
Clearside Biomedical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Clearside Biomedical's Buy-and-hold return. Our buy-and-hold chart shows how Clearside Biomedical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Clearside Biomedical Market Price Analysis
Market price analysis indicators help investors to evaluate how Clearside Biomedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Clearside Biomedical shares will generate the highest return on investment. By understating and applying Clearside Biomedical stock market price indicators, traders can identify Clearside Biomedical position entry and exit signals to maximize returns.
Clearside Biomedical Return and Market Media
The median price of Clearside Biomedical for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 is 1.11 with a coefficient of variation of 12.23. The daily time series for the period is distributed with a sample standard deviation of 0.14, arithmetic mean of 1.15, and mean deviation of 0.11. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Gibney Anthony S of 45000 shares of Clearside Biomedical at 1.29 subject to Rule 16b-3 | 08/30/2024 |
2 | Clearside Biomedicals Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study | 10/09/2024 |
3 | Clearside Biomedical Price Target Increased to 6.00 by Analysts at Needham Company LLC | 10/14/2024 |
4 | Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024 | 10/31/2024 |
5 | Acquisition by Chong Ngai Hang Victor of 36500 shares of Clearside Biomedical at 1.0 subject to Rule 16b-3 | 11/01/2024 |
6 | Celldex Therapeutics Reports Q3 Loss, Tops Revenue Estimates | 11/06/2024 |
7 | Ngai Hang Victor Chong Purchases 36,500 Shares of Clearside Biomedical, Inc. Stock | 11/07/2024 |
8 | Clearside Biomedical, Inc. Reports Q3 Loss, Tops Revenue Estimates | 11/12/2024 |
9 | Clearside Biomedical, Inc. Q3 2024 Earnings Call Transcript | 11/13/2024 |
10 | Clearside Biomedical, Inc. Receives Average Recommendation of Buy from Brokerages - MarketBeat | 11/21/2024 |
About Clearside Biomedical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Clearside or other stocks. Alpha measures the amount that position in Clearside Biomedical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2023 | 2024 (projected) | Payables Turnover | 0.0225 | 0.16 | 0.11 | Days Of Inventory On Hand | 1.9K | 1.7K | 1.5K |
Clearside Biomedical Upcoming Company Events
As portrayed in its financial statements, the presentation of Clearside Biomedical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Clearside Biomedical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Clearside Biomedical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Clearside Biomedical. Please utilize our Beneish M Score to check the likelihood of Clearside Biomedical's management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Clearside Biomedical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Clearside Biomedical Backtesting, Clearside Biomedical Valuation, Clearside Biomedical Correlation, Clearside Biomedical Hype Analysis, Clearside Biomedical Volatility, Clearside Biomedical History and analyze Clearside Biomedical Performance. For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Clearside Biomedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.